These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8037001)

  • 21. [Clinical studies of Magurlit granulates].
    Frang D; Verebélyi A; Nagy Z
    Acta Chir Acad Sci Hung; 1978; 19(4):363-72. PubMed ID: 757918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hazards and contraindications of instrumental chemolysis of renal calculi].
    Timmermann A; Kallistratos G
    Urol Int; 1968; 23(3):236-43. PubMed ID: 4968719
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathophysiology and management of calcium stones.
    Park S; Pearle MS
    Urol Clin North Am; 2007 Aug; 34(3):323-34. PubMed ID: 17678983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical and chemical characteristics of renal stone matrix.
    Malagodi MH; Moye HA
    Urol Surv; 1981 Aug; 31(4):87-91. PubMed ID: 6794208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microstructural matrix-crystal interactions in calcium oxalate monohydrate kidney stones.
    Stacholy J; Goldberg EP
    Scan Electron Microsc; 1985; (Pt 2):781-7. PubMed ID: 3931207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of uropontin in calcium oxalate lithogenesis].
    Paulhac P; Desgrandchamps F; Dumas JP; Teillac P; Le Duc A; Colombeau P
    Prog Urol; 2002 Feb; 12(1):114-7. PubMed ID: 11980003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple calcium oxalate stone formation in a patient with glycogen storage disease type I (von Gierke's disease) and renal tubular acidosis type I: a case report].
    Kanematsu A; Segawa T; Kakehi Y; Takeuchi H
    Hinyokika Kiyo; 1993 Jul; 39(7):645-8. PubMed ID: 8362684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Instrumental chemolysis of cystine calculi].
    Minervini MS; Dormia G; Luongo P; Malagola G; Castellani R; Bertana F; Gonnella G; Mazza L; Longo G; Di Giacomo N
    Arch Ital Urol Androl; 1994 Dec; 66(5):249-52. PubMed ID: 7812304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 33. Do organic substances act as a degradable binding matrix in calcium oxalate kidney stones?
    Adelman A; Shilo Y; Modai J; Leibovici D; Dror I; Berkowitz B
    BMC Urol; 2021 Mar; 21(1):46. PubMed ID: 33765979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.
    Meyer JL
    Invest Urol; 1981 Nov; 19(3):197-201. PubMed ID: 7298292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystalline composition of equine urinary calculi.
    Mair TS; Osborn RS
    Res Vet Sci; 1986 May; 40(3):288-91. PubMed ID: 3738224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New chemolysis for urological calcium phosphate calculi - a study in vitro.
    Xiang-bo Z; Zhi-ping W; Jian-min D; Jian-zhong L; Bao-liang M
    BMC Urol; 2005 May; 5():9. PubMed ID: 15907215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-year observations with Magurlit, a stone-dissolving granulate.
    Baranyai E; Kis E; Szebeni R
    Ther Hung; 1980; 28(4):177-9. PubMed ID: 7209851
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analytical evaluation of urinary calculi mineral composition].
    Machoy P
    Ann Acad Med Stetin; 1995; 41():259-71. PubMed ID: 8615550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic investigation of calcium oxalate urinary lithiasis. Indicators of lithogenic risk: modalities, applications and perspectives].
    Robert M
    Prog Urol; 1996 Feb; 6(1):44-51. PubMed ID: 8624527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacotherapy for preventing calcium containing stone formation].
    Nagata M; Takayama T; Mugiya S; Ohzono S
    Clin Calcium; 2011 Oct; 21(10):1530-4. PubMed ID: 21960240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.